Programme
Meeting Banner

We are pleased to confirm the below programme for BSPED 2018.

07:45 - 08:45 
Sponsored Symposium
08:00 - 19:00 
Registration
08:45 - 09:00 
Endocrine Main Meeting: Welcome from Convenors
The Studio
08:45
The Studio
Session starts at 08:45
Welcome from Convenors

09:00 - 10:30 
Endocrine Main Meeting: Oral Communications 4
The Studio
Chairs: Mehul Dattani (London) & Helen Storr (London)
09:10
The Studio
Session starts at 09:00
OC4.1
Hydrocortisone granules in capsules for opening: phase 3 trial in children with adrenal insufficiency and long-term safety data
Alexander Lewis (Cardiff)

09:20
The Studio
Session starts at 09:00
OC4.2
Gene expression signatures in children with growth hormone deficiency (GHD) and Turner syndrome (TS) predict response to growth hormone
Adam Stevens (Manchester)

09:30
The Studio
Session starts at 09:00
OC4.3
Recommendations for management of paediatric phaeochromocytoma/paraganglioma (PCC/PGL):On behalf of the UK Paediatric PCC/PGL Guideline Development Group.
Prateek Yadev (London)

09:40
The Studio
Session starts at 09:00
OC4.4
Identification and characterisation of a small-molecule ACTH receptor/Melanocortin-2-receptor antagonist
Li Chan (London)

09:50
The Studio
Session starts at 09:00
OC4.5
Delayed or Absent? - Use of Next Generation Sequencing Diagnostic Tools in a UK Puberty Cohort
Sasha Howard (London)

10:00
The Studio
Session starts at 09:00
OC4.6
Implementation of a novel non-invasive test for monitoring control in individuals with congenital adrenal hyperplasia
Irina Bacila (Sheffield)

10:10
The Studio
Session starts at 09:00
OC4.7
Clinical Outcomes of Focal Congenital Hyperinsulinism - A UK Perspective

10:20
The Studio
Session starts at 09:00
OC4.8
Prolactinoma in Childhood and Adolescence – outcomes relating to the size of tumour
Ved Bhushan Arya (London)

09:00 - 10:30 
Diabetes Professionals Day: Session 1
The Suites
Chair: Lesley Drummond (Birmingham)
09:00
The Suites
Session starts at 09:00
S1.1
Diasend Project
John Pemberton (Birmingham)

09:30
The Suites
Session starts at 09:00
S1.2
Social media and diabetes management - does it work?
Libby Dowling (London)

10:00
The Suites
Session starts at 09:00
S1.3
Optimising Transition in Young Adults with Diabetes - the importance of hope?

09:00 - 09:45 
Endocrine Main Meeting - Nurses' AGM
Chairs: Stephanie Kerr (Southampton) & Kate Davies (London)
09:45 - 10:30 
PENS Presentation Session
Chairs: Stephanie Kerr (Southampton) & Kate Davies (London)
09:45

Session starts at 09:45
PENS1.1
Polycystic Kidney Disease with Hyperinsulinemic hypoglycaemia
Kate Morgan (London)

10:05

Session starts at 09:45
PENS1.2
PENS BSPED Prize: The Implementation of a Nurse Led Virtual Thyroid Clinic
Christine Desmond (Reading)

10:30 - 11:00 
Tea & Coffee
Mezzanine
11:00 - 11:30 
Diabetes Professionals' Day: Oral Communications 6
The Suites
Chairs: Ruth Krone (Birmingham) & Heather Stirling (Coventry)
11:00
The Suites
Session starts at 11:00
OC6.1
A Retrospective Regional Analysis of Outcomes during Transition of Young People with Type 1 Diabetes
Melanie Kershaw (Birmingham)

11:10
The Suites
Session starts at 11:00
OC6.2
Perceptions of diabetes education: a questionnaire-based survey of 117 patients and families.
Allison Low (Sheffield)

11:20
The Suites
Session starts at 11:00
OC6.3
Has the reduction in maintenance fluid rates following introduction of 2015 BSPED-recommended diabetic ketoacidosis guidelines impacted on complication rates?
Amish Chinoy (Manchester)

11:00 - 12:30 
Symposium 1
DSD/Adrenals
The Studio
Chair: Jeremy Kirk (Birmingham)
11:00
The Studio
Session starts at 11:00
SY1.1
Diagnostic approach to expanding aetiologies of DSD
Nils Krone (Sheffield)

11:30
The Studio
Session starts at 11:00
SY1.2
DSD surgery; the child’s best interests, and disclosure prior to consent
Robert Wheeler (Southampton)

12:00
The Studio
Session starts at 11:00
SY1.3
Novel androgen pathways and their role in CAH
Wiebke Arlt (Birmingham)

11:30 - 12:30 
Diabetes Professionals Day: Session 2
Type II diabetes
The Suites
Chair: Martha Ford-Adams (London)
11:30
The Suites
Session starts at 11:30
S2.1
Type 2 diabetes: insights from the adult clinic
Katharine Owen (Oxford)

12:00
The Suites
Session starts at 11:30
S2.2
New Therapies in Type 2 diabetes
Billy White (London)

12:30 - 13:30 
Lunch, exhibition & poster tours
Mezzanine
13:30 - 14:30 
Diabetes Professionals: Session 3
Technology in Diabetes
The Suites
Chair: Chizo Agwu (Birmingham)
13:30
The Suites
Session starts at 13:30
S3.1
CGMS in children - current technologies and future prospects
Carlo Acerini (Cambridge)

14:00
The Suites
Session starts at 13:30
S3.2
Practical Approach to Management of CGM and Flash Glucose (Libre) Systems for Children and Young People with T1DM
May Ng (Ormksirk)

13:30 - 14:30 
Endocrine Main Meeting: Oral Communications 5
The Studio
Chairs: Ved Bhusan Arya (London) & Liz Crowne (Bristol)
13:30
The Studio
Session starts at 13:30
OC5.1
Growth outcomes in adolescents and adults with Silver-Russell syndrome and the effects of childhood growth hormone treatment.
Oluwakemi Lokulo-Sodipe (Southampton)

13:36
The Studio
Session starts at 13:30
OC5.2
Screening for Co-Morbidities in Fibrous Dysplasia
Zilla Huma (London)

13:42
The Studio
Session starts at 13:30
OC5.3
Can novel stem cell models help unpick the pathogenesis of the Triple A Syndrome?

13:48
The Studio
Session starts at 13:30
OC5.4
Fourteen years experience of hydrocortisone pump therapy for cortisol replacement in adrenal insufficiency
Peter Hindmarsh (London)

13:54
The Studio
Session starts at 13:30
OC5.5
New insights into the Low Dose Dexamethasone Suppression Test in paediatric Cushing’s Syndrome (CS)

14:00
The Studio
Session starts at 13:30
OC5.6
Successes and challenges around cohorted introduction of Burosumab in clinical treatment of X-Linked Hypophosphataemia (XLH)
Ian Tucker (Bristol)

14:06
The Studio
Session starts at 13:30
OC5.7
A novel GHR pseudoexon mutation causing frameshift and severe postnatal growth failure
Emily Cottrell (London)

14:12
The Studio
Session starts at 13:30
OC5.8
Patients with short stature and GH/IGF-1 Insensitivity harbour Copy Number Variants causing a Silver-Russell-like Phenotype
Emily Cottrell (London)

14:18
The Studio
Session starts at 13:30
OC5.9
Diazoxide-induced pulmonary hypertension: UK multicentre retrospective study on the risk factors, monitoring approach andmanagement recommendations
Suet Ching Chen (Glasgow)

14:30 - 15:30 
Tea, coffee & poster tours
Mezzanine
15:30 - 16:30 
Symposium 2
Bone health and disease
The Studio
Chair: Paul Arundel (Sheffield)
15:30
The Studio
Session starts at 15:30
SY2.1
Vitamin D - Beyond Bone
Martin Hewison (Birmingham)

16:00
The Studio
Session starts at 15:30
SY2.2
State of the Art Lecture: 20 years experience in Metabolic Bone
Nicholas Shaw (Birmingham)

15:30 - 16:30 
Diabetes Professionals Day: Session 4
Debate
The Suites
Chair: Melanine Kershaw (Birmingham)
15:30
The Suites
Session starts at 15:30
S4.1
FOR: This house believes that Automation has primacy over Education in management of diabetes
Tabitha Randell (Nottingham)

16:00
The Suites
Session starts at 15:30
S4.2
AGAINST: This house believes that Automation has primacy over Education in management of diabetes
Fiona Campbell (Leeds)

16:30 - 17:00 
Key Note Speaker: Session 5
Bone health and disease
The Studio
16:30
The Studio
Session starts at 16:30
S5
Palaeopathology; diseases and excavations
Anthony Waldron (London)

16:30 - 17:00 
Key Note Speaker: Session 5
Bone health and disease
The Studio
16:30
The Studio
Session starts at 16:30
S5
Palaeopathology; diseases and excavations
Anthony Waldron (London)

17:15 - 18:15 
BSPED AGM
The Studio